Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare non-coverage decision on CaverMap

This article was originally published in Clinica

Executive Summary

US Medicare has decided not to cover a test that is used to determine whether the nerves linked to sexual function in men have been damaged following prostatic or colorectal surgery. The test, known as cavernous nerves electrical stimulation with penile plethysmography, uses a special sensor to measure a change in penile girth when intact nerves are stimulated.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052006

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel